COEPTIS THERAPEUTICS HOLDING (COEP) Stock Price, Quote, News and Overview
NASDAQ:COEP - Nasdaq - US19207A1088 - Common Stock - Currency: USD
COEP Quote, Performance and Key Statistics
COEPTIS THERAPEUTICS HOLDING
NASDAQ:COEP (1/28/2025, 8:00:00 PM)
11.21
-1.67 (-12.97%)
The current stock price of COEP is 11.21 USD. In the past month the price increased by 165.64%. In the past year, price increased by 0.09%.
COEP Latest News, Press Releases and Analysis
Which stocks are gapping on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy...
Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy...
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket
Why Is Coeptis Therapeutics Stock Falling On Friday?
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares are trading lower on Friday. The firm announced plans to implement a 1-for-20 reverse stock split, which will take effect on December 31. The decision follows authorization from the company's board of directors and majority stockholders. The reverse stock split aims to help the company meet the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share, which is necessary to maintain its listing on the exchange. Also Read: 3
COEP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.26 | 308.91B | ||
| AMGN | AMGEN INC | 14.58 | 150.67B | ||
| GILD | GILEAD SCIENCES INC | 21.19 | 116.96B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 864.08 | 113.49B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.11 | 75.42B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.75B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 36.01B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.96B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.13B | ||
| NTRA | NATERA INC | N/A | 22.19B | ||
| BIIB | BIOGEN INC | 8.91 | 21.20B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.33B |
Related stock screener links
About COEP
Company Profile
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company. The company is headquartered in Wexford, Pennsylvania and currently employs 5 full-time employees. The company went IPO on 2020-12-17. The firm owns, acquires, and develops cell therapy technologies for cancer and other diseases. Its product portfolio and rights are highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company is developing a universal, multi-antigen chimeric antigen receptor (CAR) T technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells are genetically engineered to recognize cancer cells to target and destroy them.
Company Info
COEPTIS THERAPEUTICS HOLDING
105 Bradford Road, Suite 420
Wexford PENNSYLVANIA US
Employees: 6
Company Website: https://coeptistx.com/
Investor Relations: http://coeptis.investorroom.com
Phone: 17249346467
COEP FAQ
What is the stock price of COEP?
The current stock price of COEP is 11.21 USD.
What is the symbol for COEPTIS THERAPEUTICS HOLDING stock?
The exchange symbol of COEPTIS THERAPEUTICS HOLDING is COEP and it is listed on the Nasdaq exchange.
On which exchange is COEP stock listed?
COEP stock is listed on the Nasdaq exchange.
Is COEP a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for COEP, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of COEP.
Does COEP stock pay dividends?
COEP does not pay a dividend.
What is the Price/Earnings (PE) ratio of COEP?
COEP does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.88).
COEP Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to COEP. When comparing the yearly performance of all stocks, COEP is one of the better performing stocks in the market, outperforming 96.47% of all stocks.
COEP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to COEP. Both the profitability and financial health of COEP have multiple concerns.
COEP Financial Highlights
Over the last trailing twelve months COEP reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS increased by 74.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -260.16% | ||
| ROE | -486.74% | ||
| Debt/Equity | 0.03 |
COEP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to COEP. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 69.41% and a revenue growth -100% for COEP